Philipp K. Haber
机构:Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, Icahn School of Medicine at Mount Sinai · ORCID:0000-0001-9685-9562
发表论文 120 篇 · 总被引 4691 次 · h-index 23
代表论文
- Single-cell RNA sequencing-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 61)
- Robotic versus laparoscopic versus open major hepatectomy – an analysis of costs and postoperative outcomes in a single-center setting (2023 · Langenbeck s Archives of Surgery · 被引 19)
- Biliary microbial patterns in primary sclerosing cholangitis are linked to poorer transplant-free survival (2023 · Hepatology Communications · 被引 9)
- Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesis (2025 · JHEP Reports · 被引 5)
- TOP-507-YI Single-cell RNA sequencing-derived gene signatures reveal distinct response mechanisms to atezolizumab + bevacizumab in advanced hepatocellular carcinoma (2024 · Journal of Hepatology · 被引 3)
- Adherence to Multidisciplinary Tumor Board Decisions Determines Long-term Survival in Patients with Hepatocellular Carcinoma (2025 · Annals of Surgery · 被引 1)